Eugene A. Snyder Jr., PA

Eugene Snyder practices at Skinpath Solutions, Inc in Smyrna, Georgia.

Eugene Snyder's NPI, 1528330545, was assigned on February 7, 2012. Eugene Snyder holds Pennsylvania license MA055101.

Eugene Snyder's primary practice is Skinpath Solutions, Inc, at 2000 Lake Park SE Dr, Smyrna, GA 30080 in Cobb County. The practice phone is (678) 556-9411.

Eugene Snyder's primary practice is Skinpath Solutions, Inc in Smyrna, Georgia. The medical group on file is Live Oak Dermatology. Dmand AI also links Eugene Snyder to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Eugene Snyder practices, 2 sites in all. Vendor and product names are available with a free account.

Physician assistant is Eugene Snyder's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Eugene Snyder is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Eugene Snyder is licensed in Pennsylvania.

Dmand AI lists acne, arteritis, benign or precancerous skin growths, contact dermatitis, hand joint or tendon inflammation, itchy rashes, minor injury on trunk and psoriasis among the conditions Eugene Snyder treats.

CMS data shows 2,352 Medicare services from Eugene Snyder across 11 procedure codes in 2024, for 669 Medicare patients. Medicare paid $61,998 for them. Every service was in an office.

CMS counts 669 Medicare patients who saw Eugene Snyder in 2024. The largest group is 65 to 74, with 284 patients. 75% of them have high cholesterol, and 66% have high blood pressure. 16% are also on Medicaid. Their average risk score is 0.92, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Eugene Snyder's median patient age at 55, with 35% women.

In 2024, Eugene Snyder wrote 994 Medicare Part D claims for 373 patients. 90% of them were for generic drugs. CMS names the drug for 864 of them, across 19 drugs with 11 or more claims each, at $118,416 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Eugene Snyder for performance year 2024, reported through an alternative payment model (APM). Eugene Snyder accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 37 general payments to Eugene Snyder from 10 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $186.